ANIP ANI PHARMACEUTICALS INC

8-K Current Report

Filed: February 27, 2026

Health Care

Pharmaceutical Preparations

ANI PHARMACEUTICALS INC (ANIP) 8-K current report filed with SEC EDGAR on February 27, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 or full-year results reported by ANI Pharmaceuticals (ANIP), signed February 27, 2026 — refer to accompanying exhibit for key figures
• CFO Stephen P. Carey authorized the filing; actual financial results contained in the press release exhibit, not the filing body

Other ANI PHARMACEUTICALS INC 8-K Filings

8-K Mar 3, 2026

Get deeper insights on ANI PHARMACEUTICALS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.